Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology

BACKGROUND: Chinese traditional herbal medicine Fuzhengkangai (FZKA) formulation combination with gefitinib can overcome drug resistance and improve the prognosis of lung adenocarcinoma patients. However, the pharmacological and molecular mechanisms underlying the active ingredients, potential targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bing, Zhitong, Cheng, Zhiyuan, Shi, Danfeng, Liu, Xinkui, Tian, Jinhui, Yao, Xiaojun, Zhang, Jingyun, Wang, Yongfeng, Yang, Kehu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218988/
https://www.ncbi.nlm.nih.gov/pubmed/30400936
http://dx.doi.org/10.1186/s12906-018-2347-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218988/
https://www.ncbi.nlm.nih.gov/pubmed/30400936
http://dx.doi.org/10.1186/s12906-018-2347-x

Ejemplares similares